title: Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?
authors.affiliation: Cell Transformation Group, Department of Pathology, School of Medicine, University of Otago, Dunedin, New Zealand.
authors.forename: B R
authors.initials: BR
authors.lastname: Dix
authors.forename: S J
authors.initials: SJ
authors.lastname: Edwards
authors.forename: A W
authors.initials: AW
authors.lastname: Braithwaite
mesh_terms: D000256:Adenoviridae / Q000378:metabolism; D017501:Adenovirus E1B Proteins / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000378:metabolism / Q000628:therapy* / Q000821:virology; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*
chemical_list: D017501:Adenovirus E1B Proteins; D016159:Tumor Suppressor Protein p53